113 related articles for article (PubMed ID: 4679953)
1. [The etiopathogenic role of long-acting thyroid stimulator in thyrotoxicosis].
Papazov G; Milanov S; Platonova E
Vutr Boles; 1972; 11(2):59-62. PubMed ID: 4679953
[No Abstract] [Full Text] [Related]
2. Long-acting thyroid stimulator (LATS) in hyperthyroidism and exophthalmos.
Friis T
Dan Med Bull; 1969 Nov; 16(10):294-304. PubMed ID: 5392781
[No Abstract] [Full Text] [Related]
3. ["Long-acting thyroid stimulator" and thyrotropic hormone in thyrotoxicosis in newborn infants].
Gautier E; Juillard E; Lemarchand-Béraud T
Schweiz Med Wochenschr; 1968 Jan; 98(1):8-12. PubMed ID: 5695264
[No Abstract] [Full Text] [Related]
4. Immunoglobulin levels and long-acting thyroid stimulator (LATS) in hyperthyroidism. A preliminary study.
Yamakido M; Yokoyama M; Noguchi S
Hawaii Med J; 1969; 29(2):118-9. PubMed ID: 5361480
[No Abstract] [Full Text] [Related]
5. Epidemiology and pathogenesis of iodine-induced thyrotoxicosis in Northern Tasmania.
Stewart JC
N Z Med J; 1975 Jan; 81(531):25-6. PubMed ID: 1055312
[No Abstract] [Full Text] [Related]
6. [TSH and the "long-acting thyroid stimulator" (LATS) in patients with compensated hyperthyroidism].
zur Mühlen A von ; Hesch RD; von Lilienfeld H; Emrich D
Acta Endocrinol Suppl (Copenh); 1971; 152():86. PubMed ID: 5313711
[No Abstract] [Full Text] [Related]
7. [Pitfalls in the biological demonstration of the "long acting thyroid stimulator" (LATS)].
Mertz DP; Stelzer M
Schweiz Med Wochenschr; 1968 Sep; 98(38):1471-5. PubMed ID: 5680881
[No Abstract] [Full Text] [Related]
8. [Long-acting thyroid stimulator (LATS), thyrotropin (TSH) and the pathogenesis of hyperthyroidism].
Lamberg BA; Gordin A
Nord Med; 1968 Dec; 80(49):1651-7. PubMed ID: 5757398
[No Abstract] [Full Text] [Related]
9. [Significance of the "long acting thyroid stimulator"].
Tourneur R; Letonturier P; Sénécal P
Cah Med; 1974 Mar; 15(3):121-3. PubMed ID: 4479615
[No Abstract] [Full Text] [Related]
10. [Fluctuations of the long-acting thyroid stimulator (LATS) concentration in the blood and its significance in hyperthyroidism].
Noguchi A; Kurihara H; Ozeki Y; Sato S
Nihon Rinsho; 1967 Oct; 25(8):1723-32. PubMed ID: 5626106
[No Abstract] [Full Text] [Related]
11. Neonatal thyrotoxicosis with long acting thyroid stimulator-protector.
O'Hearlihy C
Ir Med J; 1977 Mar; 70(4):124-5. PubMed ID: 576864
[No Abstract] [Full Text] [Related]
12. [The long acting thyroid stimulator (LATS) in some thyroid diseases. Preliminary results].
Busnardo B; Accordi F; Debiasi S
Acta Isot (Padova); 1968 Oct; 8(2):165-79. PubMed ID: 5761578
[No Abstract] [Full Text] [Related]
13. [Neonatal hyperthyroidism and thrombopenic purpura].
Moro Serrano M; Pérez Martínez A; Mariscal Ramos E; Casado de Frías E
An Esp Pediatr; 1983 May; 18(5):384-7. PubMed ID: 6688508
[TBL] [Abstract][Full Text] [Related]
14. [The determination of long-acting thyroid stimulator (LATS) in thyroid diseases].
Depisch D; Höfer R; Schatz H
Wien Z Inn Med; 1968; 49(4):121-30. PubMed ID: 5757238
[No Abstract] [Full Text] [Related]
15. The role of long acting thyroid stimulator in neonatal thyrotoxicosis.
Maisey MN; Stimmler L
Clin Endocrinol (Oxf); 1972 Jan; 1(1):81-90. PubMed ID: 4677121
[No Abstract] [Full Text] [Related]
16. [Non-fatal case of neonatal thyrotoxicosis with serial determination of LATS].
Tsuji A; Koshimizu T; Kato K
Horumon To Rinsho; 1970 May; 18(5):417-20. PubMed ID: 5465536
[No Abstract] [Full Text] [Related]
17. [Characterization of the long-acting thyroid stimulator. Considerations on preliminary results].
Tourneur R; Letonturier P; Sénécal P
MMW Munch Med Wochenschr; 1974 Mar; 116(13):677-9. PubMed ID: 4212576
[No Abstract] [Full Text] [Related]
18. [Determination of thyrotropic hormone and long acting thyroid stimulator by the McKenzie technique. Critical study of the method].
Bonnyns M
Rev Fr Etud Clin Biol; 1968 Nov; 13(9):845-52. PubMed ID: 5709509
[No Abstract] [Full Text] [Related]
19. Long-acting thyroid stimulator (LATS) and immunofluorescent studies in patients with pretibial myxoedema.
From E; Diederichsen H; Heydenreich G; Nielsen OS
Dan Med Bull; 1973 Dec; 20(6):188-91. PubMed ID: 4591336
[No Abstract] [Full Text] [Related]
20. [Cytogenetic studies in patients with thyroiditis and LATS and antibody-positive hyperthyroidism].
Tolksdorf M; Schemmel K; Mühlenstedt D; Uthgenannt H; Müller W
Schweiz Med Wochenschr; 1969 Jul; 99(30):1082-5. PubMed ID: 5351142
[No Abstract] [Full Text] [Related]
[Next] [New Search]
